Targeting neuronal FKBP5 attenuates mechanical allodynia by suppressing NF-κB-mediated neuroinflammation in an NTG-induced chronic migraine mouse model.

Chronic migraine is a painful condition that affects many people. This study focused on a protein called FKBP5 and its role in migraine. Researchers used a mouse model to investigate how FKBP5 affects pain and inflammation. They discovered that FKBP5 influences a specific area in the brain linked to pain. By using advanced techniques, they could see how FKBP5 changes during migraine attacks. The team also tested drugs that block FKBP5 and another protein called NF-κB. These drugs helped reduce pain and inflammation in the mice. The findings suggest that targeting FKBP5 may help treat chronic migraines by reducing pain sensitivity. This research opens new doors for developing better migraine treatments. Understanding how FKBP5 works could lead to more effective therapies for people suffering from chronic migraines and related pain conditions. Clinical relevance: Targeting FKBP5 may provide new treatment options for patients with chronic migraines.